We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$667M
AUM Growth
-$1.53M
Cap. Flow
-$63.8K
Cap. Flow %
-0.01%
Top 10 Hldgs %
30.54%
Holding
189
New
11
Increased
58
Reduced
44
Closed
12

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.98M
2
D icon
Dominion Energy
D
+$7.78M
3
CAT icon
Caterpillar
CAT
+$6.31M
4
CVS icon
CVS Health
CVS
+$1.77M
5
VFC icon
VF Corp
VFC
+$1.71M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$7.29M
2
SO icon
Southern Company
SO
+$6.41M
3
HSY icon
Hershey
HSY
+$5.71M
4
LYB icon
LyondellBasell Industries
LYB
+$4.2M
5
BFH icon
Bread Financial
BFH
+$3.97M

Sector Composition

Rank Sector Weight
1 Financials 17.92%
2 Healthcare 17.91%
3 Technology 15.93%
4 Consumer Discretionary 12.97%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CWBS
176
DELISTED
COMMONWEALTH BANKSHARES INC VA
CWBS
$0 ﹤0.01%
11,761
– –
4 5 6 7
8

Similar funds

CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return

Franklin Street Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Franklin Street Advisors held 189 positions worth $667M, down 0.23% from $668M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Franklin Street Advisors's Q1 2018 filing shows 11 new, 58 increased, 44 reduced and 12 closed positions. Its largest new stake was Celgene Corp: 15,200 shares worth $1.36M. The largest sale was Merck, an estimated $7.29M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • Franklin Street Advisors's largest Q1 2018 buy was Celgene Corp: 15,200 shares worth $1.36M.
  • Franklin Street Advisors added most to Bristol-Myers Squibb in Q1 2018, an estimated $7.98M increase.
  • Franklin Street Advisors's biggest Q1 2018 reduction was Merck, cutting an estimated $7.29M.
  • Franklin Street Advisors fully exited LyondellBasell Industries in Q1 2018, selling an estimated $4.2M.
  • Franklin Street Advisors's ten largest holdings make up 31% of its $667M portfolio in Q1 2018.
  • Franklin Street Advisors opened 11 new positions and closed 12 in Q1 2018.
  • Franklin Street Advisors's portfolio value fell 0.23% quarter-over-quarter to $667M.

Based on Franklin Street Advisors's 13F filing for Q1 2018, filed 11 Apr 2018.